Prices delayed by at least 15 minutes | Print
Zimmer Biomet Holdings (ZBH)
Common StockOpen
$119.4
Previous close
$119.35
Trade high
$121.76
Volume
1,195,031
Year high
$149.25
Year low
$102.00
Dividend yield
0.8%
Market capitalisation
$25.01 bn
P/E ratio
24.46
ISIN
US98956P1021
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 27/12/2023 | 29/03/2024 |
| Ex-dividend date | 26/12/2023 | 27/03/2024 |
| Payment date | 31/01/2024 | 30/04/2024 |
| Amount | $0.24 | $0.24 |
Company profile
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.